Biotech Values

[DewDiligence]

And yet you still have Teva speculating that since they submitted their data a month after MNTA, that perhaps the delay of obtaining approval is that the FDA has had one last month to review this data. Come on, it is August for crying out loud!. It has been at least 8 months, and 9 months for MNTA. That seems to be about as facetious of reasoning as any I can think of.

Agreed. These kinds of patently silly statements are par for the course for Bill Marth. That’s why I suggested in #msg-45522123 that Marth’s title ought to be changed to Teva’s Minister of Propaganda.

I don’t completely agree, however, that Marth’s comments in #msg-45522123 rule out the possibility that Teva has improved on the drug in the original ANDA filing. Not likely but possible, IMO.